13 completed, 1 unknown, 1 withdrawn. 8 Phase 4, 2 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 7, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Prevenar13: new trials by email Literature Review of Prevenar13 trials Research Report on Prevenar13
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults EuPCV15, Prevenar13 - Pneumococcal Disease | Phase 1 | Completed | EuBiologics Co.,Ltd | 60 | 2020-05-28 | 2021-10-07 |
| Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia PCV13, PPSV23 - CLL, Vaccine Response | Phase 4 | Completed | Region Örebro County | 77 | 2019-01-01 | 2023-03-30 |
| Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older HZ/su vaccine GSK1437173A, Prevenar13 - Herpes Zoster | Phase 3 | Completed | GlaxoSmithKline | 913 | 2018-04-12 | 2022-01-11 |
| Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules 13-valent pneumococcal conjugate vaccine (PCV13) - Immunogenicity, Vaccine, Immunologic Memory | Unknown | Aghia Sophia Children's Hospital of Athens | 60 | 2016-12-12 | 2018-01-23 | |
| PCV13 in Non-pregnant Papua New Guinean Women 13-valent pneumococcal conjugate vaccine - Pneumococcal Infections | Completed | Telethon Kids Institute | 50 | 2016-05-10 | 2019-12-17 | |
| Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients pneumococcal polysaccharide vaccine, pneumococcal conjugate vaccine, Abatacept - Rheumatoid Arthritis | Not applicable | Completed | University Hospital, Montpellier | 80 | 2016-03-03 | 2022-01-03 |
| Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults Prevenar13 - Streptococcal Pneumonia, HIV/AIDS | Phase 4 | Completed | Korea University Guro Hospital | 70 | 2015-04-02 | 2019-02-12 |
| Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Fluad and Prevenar13, Fluad, Prevenar13 - Influenza, Streptococcus Pneumoniae | Phase 4 | Completed | Korea University Guro Hospital | 1195 | 2014-09-01 | 2015-04-01 |
| PCV13 + Hepatitis A Vaccine for Adults Prevenar13, Hepatitis A vaccine - Measurement of Immune Response to Prevenar13, Measurement of Immune Response to Hepatitis A | Phase 4 | Completed | Helsinki University Central Hospital | 305 | 2013-08-24 | 2024-12-05 |
| PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency Prevenar13 - IgG Deficiency | Phase 2 | Completed | Karolinska University Hospital | 20 | 2013-05-01 | 2014-06-16 |
| Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life Prevenar13, Synflorix - Otitis Media, Febrile Illness | Phase 4 | Completed | Menzies School of Health Research | 261 | 2013-03-12 | 2020-03-25 |
| Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients Prevenar13, Pneumovax - Kidney Transplantation, Liver Transplantation | Phase 4 | Completed | Helsinki University Central Hospital | 182 | 2013-01-01 | 2017-10-05 |
| Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults pneumococcal conjugate 13 valent vaccine - HIV Infection, Pneumococcal Infections | Phase 3 | Completed | University of Siena | 50 | 2011-12-01 | 2014-04-25 |
| Pneumococcal Vaccines Early and in Combination Synflorix, Prevenar13, COMBO - Otitis Media | Phase 4 | Completed | Menzies School of Health Research | 425 | 2011-08-01 | 2018-10-18 |
| Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants Synflorix, Prevenar13 - Vaccination, Immunization | Phase 4 | Withdrawn | Public Health England | 2019-08-28 |
Pneumococcal Infections (3) · Otitis Media (2) · Acquired Immunodeficiency Syndrome (1) · Arthritis, Rheumatoid (1) · Cough (1) · HIV Infections (1) · Hepatitis (1) · Herpes Zoster (1) · IgG Deficiency (1) · Influenza, Human (1) · Pneumonia (1) · Respiratory Tract Infections (1)
Helsinki University Central Hospital (2) · Korea University Guro Hospital (2) · Menzies School of Health Research (2) · Aghia Sophia Children's Hospital of Athens (1) · EuBiologics Co.,Ltd (1) · GlaxoSmithKline (1) · Karolinska University Hospital (1) · Public Health England (1) · Region Örebro County (1) · Telethon Kids Institute (1) · University Hospital, Montpellier (1) · University of Siena (1)
Sweden (3) · Australia (2) · Finland (2) · South Korea (2) · Canada (1) · Estonia (1) · France (1) · Germany (1) · Greece (1) · Italy (1) · Monaco (1) · Papua New Guinea (1) · United Kingdom (1) · United States (1)
Amanda J Leach, PhD (2) · Anu Kantele, Assoc. prof. (1) · Bertil Uggla, Md, PhD (1) · Elizabeth Coates, PhD (1) · Francesca Montagnani, MD, PhD (1) · Hee Jin Cheong, MD, PhD (1) · Jacques Morel, MD PhD (1) · Joon Young Song, MD, PhD (1) · Lars Rombo, Professor (1) · Peter W Bergman, MD, PhD (1) · Vana Spoulou, MD, PhD (1) · Veli-Jukka Anttila, MD,PhD,Docent (1)
PMID 35772449, PMID 38829821, PMID 25596202, PMID 26506438, PMID 27258647, PMID 27919632, PMID 28410816, PMID 31364010, PMID 32448790, PMID 33292822, PMID 33685411, PMID 34963639, PMID 37572831, PMID 40045895
2017 (1)